IP And Trademarks 25 September 2026
Autonomix Medical Secures European Patent for Neural Assessment Tech
Autonomix Medical has been granted a European patent for its neural assessment technology, expanding its IP portfolio that covers autonomic nervous system diagnostics. The approval bolsters the firm’s market position in Europe.
Autonomix Medical announced it has received a European patent covering its neural assessment technology, which evaluates the autonomic nervous system. Read the full announcement.
- Strengthens Autonomix’s IP portfolio across Europe
- Opens broader market opportunities for its diagnostics
- Enhances competitive edge in autonomic nervous system assessments
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.